Primary outcomes from a randomized, Phase III study of belatacept vs cyclosporine in ECD kidney transplants (BENEFIT-EXT Study)

dc.contributor.authorDurrbach, Antoine
dc.contributor.authorLarsen, Christian P.
dc.contributor.authorPestana, Jose Osmar Medina [UNIFESP]
dc.contributor.authorVanrenterghem, Yves
dc.contributor.authorVincenti, Flavio
dc.contributor.authorFlorman, Sander
dc.contributor.authorBlock, A. J.
dc.contributor.authorGarg, Pushkal
dc.contributor.authorSen, K.
dc.contributor.authorGrinyo, Josep M.
dc.contributor.institutionUniv Paris 11
dc.contributor.institutionEmory Univ
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUniv Hosp Kuleuven
dc.contributor.institutionUniv Calif San Francisco
dc.contributor.institutionTulane Univ Med Ctr Hosp & Clin
dc.contributor.institutionUniv Hosp Bellvitge
dc.contributor.institutionBristol Myers Squibb Co
dc.date.accessioned2018-06-18T12:15:05Z
dc.date.available2018-06-18T12:15:05Z
dc.date.issued2009-08-01
dc.description.affiliationUniv Paris 11, Nephrol & Anatomopathol Unit, Le Kremlin Bicetre, France
dc.description.affiliationEmory Univ, Sch Med, Emory Transplant Ctr, Atlanta, GA USA
dc.description.affiliationHosp Rim & Hipertensao Unifesp, Div Nephrol, Sao Paulo, Brazil
dc.description.affiliationUniv Hosp Kuleuven, Div Nephrol, Louvain, Belgium
dc.description.affiliationUniv Calif San Francisco, Transplant Ctr, San Francisco, CA 94143 USA
dc.description.affiliationTulane Univ Med Ctr Hosp & Clin, Dept Surg, New Orleans, LA USA
dc.description.affiliationUniv Hosp Bellvitge, Div Nephrol, Barcelona, Spain
dc.description.affiliationBristol Myers Squibb Co, Immunol, Princeton, NJ USA
dc.description.affiliationUnifespHosp Rim & Hipertensao Unifesp, Div Nephrol, Sao Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent89-89
dc.identifierhttp://dx.doi.org/10.1111/j.1432-2277.2009.00961.x
dc.identifier.citationTransplant International. Malden: Wiley-blackwell Publishing, Inc, v. 22, n. suppl s2, p. 89-89, abstr. O-333, 2009.
dc.identifier.doi10.1111/j.1432-2277.2009.00960.x
dc.identifier.issn0934-0874
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/45680
dc.identifier.wosWOS:000269392800330
dc.language.isoeng
dc.publisherWiley-Blackwell
dc.relation.ispartofTransplant International
dc.rightsAcesso aberto
dc.rights.licensehttp://olabout.wiley.com/WileyCDA/Section/id-406071.html
dc.titlePrimary outcomes from a randomized, Phase III study of belatacept vs cyclosporine in ECD kidney transplants (BENEFIT-EXT Study)en
dc.typeResumo
Arquivos